Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 5, 2022, Patricia Kennedy as a member of the Board of Directors of
Biotricity Inc. (the "Company"), a member of the Company's Audit Committee, and
a member of the Company's Nominating and Corporate Governance Committee,
resigned from the Company's Board of Directors effective August 5, 2022.
Patricia Kennedy did not advise the Company of any disagreement with the Company
on any matter relating to its operations, policies or practices.
On August 5, 2022, Norman Betts as a member of the Board of Directors of
Biotricity Inc. (the "Company") and a member of the Company's Audit Committee,
resigned from the Company's Board of Directors effective August 5, 2022. Norman
Betts did not advise the Company of any disagreement with the Company on any
matter relating to its operations, policies or practices.
On August 11, 2022, the Board of Directors of the Company appointed Chester
White to the Board of Directors to fill the vacancy created by Patricia
Kennedy's resignation. There are no arrangements or understandings between Mr.
White and any other persons pursuant to which he was selected as a director. Mr.
White will receive compensation as a non-employee director in accordance with
the company's non-employee director compensation practice. Mr. White has no
direct or indirect material interest in any transaction required to be disclosed
pursuant to Item 404(a) of Regulation S-K. Mr. White has not yet been appointed
to any committees of the Board of Directors.
Mr. White is a performance driven executive with leadership in fund management,
venture capital, private equity, hedge funds, investment banking, mergers and
acquisitions, strategy consulting, and technology innovation (AI, blockchain,
cyber, mobile, cloud, enterprise software, robotics, automation, healthcare).
Mr. White holds hands on experience across a spectrum of functions (investment,
board level, strategic. operations, and restructurings) and size (startup to
fortune 500, private and public).
© Edgar Online, source Glimpses
BIOTRICITY, INC. 
